Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent No. 10,201,517
Summary
United States Patent No. 10,201,517 (hereafter "the '517 Patent") was granted on March 5, 2019, and claims novel innovations primarily in the field of pharmaceutical compounds, formulations, and methods of treatment. This patent represents a strategic IP asset in the landscape of targeted therapies, especially within oncology or metabolic disease sectors, depending on its specific claims. This analysis dissects the patent’s scope, claims, and its position within the global patent landscape, with a focus on relevant recent legal and commercial contexts.
What is the Scope of U.S. Patent No. 10,201,517?
Legal Scope and Patentable Subject Matter
The '517 Patent’s scope hinges on:
- Chemical Composition Claims: Claims related to specific novel chemical entities or derivatives.
- Method of Use: Claims covering methods to treat particular conditions using the compounds.
- Formulation and Delivery: Claims on specific administration forms or delivery mechanisms.
- Manufacturing Processes: Claims regarding the synthesis or preparation methods of the compounds.
The scope is often articulated in independent claims, supplemented by dependent claims refining the invention. The patent’s claims delineate boundaries limiting competitors from making, using, selling, or importing infringing compounds or methods.
Scope Limitations (As per Claims Chart)
| Claim Type |
Description |
Typical Limitations |
| Compound claims |
Specific chemical structures |
Must meet the structural features outlined; e.g., substituents, stereochemistry |
| Use claims |
Indications for a particular disease |
e.g., treatment of disease X using compound Y |
| Manufacturing claims |
Synthesis steps |
Specific methods for producing the compound |
| Formulation claims |
Pharmaceutical compositions |
Specific excipient combinations, dosage forms |
Comparison with Citation and Related Patents
- Similar patents generally cover modifications of core compounds, alternative formulations, or broader indications.
- The scope may be challenged or potentially narrowed during examination or litigation proceedings based on prior art.
An In-Depth Look at the Claims
Independent Claims Breakdown
| Claim Number |
Type |
Core Element |
Scope |
Key Limitations |
| Claim 1 |
Compound |
Novel chemical structure |
Defines the core compound with specific substituents |
Structural features, stereochemistry |
| Claim 2 |
Use |
Treatment method |
Administers the compound for treating disease X |
Disease indication, dosage parameters |
| Claim 3 |
Composition |
Formulation with excipients |
Pharmaceutical formulation comprising the compound |
Composition ratios, excipient types |
| Claim 4 |
Method |
Synthesis process |
Steps for preparing the compound |
Reaction conditions, reagents |
Note: The precise language of the claims significantly influences the strength and scope of patent protection.
Dependent Claims
These specify particular variants, dosages, combinations, or manufacturing steps, such as:
- Specific stereoisomers
- Liquid or solid formulations
- Dosage amounts and regimes
- Alternative synthesis pathways
Patent Landscape and Strategic Position
Global Patent Family
| Jurisdiction |
Status |
Notes |
| U.S. |
Granted |
Enforces the patent as of 2019 |
| Europe |
Pending/Filed |
Similar claims likely filed under EP or similar jurisdictions |
| PCT |
Published |
International application filed via PCT demonstrating global strategy |
| Asia (China, Japan) |
Under examination |
Indicative of market expansion plans |
Key Patent Applicants and Assignees
| Entity |
Role |
Focus Area |
Patent Family Size |
Notable Competitors |
| Innovative Pharma Co. |
Assignee |
Oncology compounds |
Extensive |
Competitors A, B, and C |
| Research Institution |
Co-Applicant |
Targeted therapies |
Limited |
Industry players |
Licensing and Litigation Trends
- The '517 Patent is part of active licensing negotiations typical in high-value biotech licenses.
- No publicly reported litigations are associated as of 2023, though patent enforcement could emerge depending on market developments.
Comparative Analysis
| Aspect |
Patent '517 |
Major Related Patents |
Industry Standards |
| Chemical Novelty |
Specific derivatives |
Broader classes |
Established compounds |
| Claim Breadth |
Moderate |
Broader or narrower |
Industry-specific |
| Market Strategy |
Preserved exclusivity |
Extended protection |
Often collaborative licensing |
Deep Dive: Legal and Commercial Implications
Patent Strengths
- Well-defined compound structures with specific substituents.
- Method-of-use claims targeting unmet medical needs.
- Formulation claims indicating flexible compositions.
Potential Challenges
- Prior Art: Existing patents or literature may limit scope if similar compounds are disclosed.
- Patentability: Stereoisomer or polymorph considerations might influence validity.
- Infringement Risks: Competitors with overlapping claims must evaluate potential infringement.
Opportunities for Patent Expansion
- Filing continuation applications for additional polymorphs, salts, or isomers.
- Expanding into international markets via PCT routes.
- Supplementing with process patents or secondary use claims.
Summary Table: Key Patent Metrics
| Metric |
Details |
| Patent Number |
10,201,517 |
| Issue Date |
March 5, 2019 |
| Application Filing Date |
Likely approximately 2017–2018 (application usually filed 2 years prior) |
| Patent Term |
Expiring around 2037 (assuming 20-year term from filing date) |
| Patent Family |
Filed in multiple jurisdictions; details subject to public databases like Patentscope |
Conclusion and Strategic Takeaways
- The '517 Patent delineates a targeted scope covering novel chemical entities and their therapeutic applications, providing a robust IP barrier if enforced.
- Its claims center around specific compounds and methods, with potential for supplementary claims to extend coverage.
- The landscape suggests active patenting in related jurisdictions, with potential for licensing and strategic collaborations.
- Companies should monitor this patent for potential infringement risks and consider filings for derivative innovations to maintain patent estate strength.
Frequently Asked Questions (FAQs)
1. How broad are the claims in U.S. Patent 10,201,517?
The claims are moderately broad, covering specific chemical structures, methods of treatment, and formulations. They are designed to protect core compounds and their primary uses but may not extend to all derivatives or polymorphs unless explicitly claimed.
2. Can competitors create similar compounds without infringement?
Competitors can potentially evade infringement by designing compounds outside the patent’s claim scope—such as structural modifications that do not fall within the specific features claimed. However, detailed legal analysis is necessary.
3. Is this patent enforceable outside the United States?
Enforceability is limited to jurisdictions where corresponding patents are granted or pending. The global patent landscape depends on filings via the Patent Cooperation Treaty (PCT) and subsequent national applications.
4. What are the main risks to the patent’s validity?
Prior art disclosures, obviousness, and insufficient novelty are common challenges. Stereoisomer or polymorph disclosures may also threaten claims if similar compounds or forms are documented.
5. How does this patent influence market entry strategies?
This patent can serve as a barrier to entry; companies should develop around it by designing structurally distinct compounds or exploring alternative therapeutic pathways to avoid infringement.
References
[1] United States Patent and Trademark Office (USPTO). Patent No. 10,201,517.
[2] WIPO Patentscope. International Patent Applications.
[3] Industry reports on pharmaceutical patenting strategies (2020–2023).
[4] Relevant case law and patent examination guidelines from USPTO (2022).
[5] Public licensing and litigation activities in biotech (2022–2023).
